Diabetes treatment is constantly advancing, with new therapeutic options appearing to improve patient outcomes. Recent research have focused on GLP-1 and GIP receptor agonists, a class of drugs that mimic the actions https://alyssadlvf559881.win-blog.com/20052136/novel-glp-1-and-gip-receptor-agonists-a-new-era-in-diabetes-treatment